Integrated imaging of non-small cell lung cancer recurrence: CT and PET-CT findings, possible pitfalls and risk of recurrence criteria

European Radiology

Volumn 22, Issue 3, 2012, Pages 588-606

  Caulo, Andrea ^a,b   Mirsadraee, Saeed ^b   Maggi, Fabio ^a   Leccisotti, Lucia ^a   Van Beek, Edwin J R ^b   Bonomo, Lorenzo ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Integrated PET CT; Local neoplasm recurrence; Multidetector row CT; Non small cell lung cancer; Recurrence

Indexed keywords

ANTINEOPLASTIC AGENT;

BONE METASTASIS; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC VALUE; DISTANT METASTASIS; HUMAN; LIVER METASTASIS; LUNG LOBECTOMY; LUNG METASTASIS; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; PRIORITY JOURNAL; PROGNOSIS; RADIOFREQUENCY ABLATION; REVIEW; STEREOTACTIC BODY RADIATION THERAPY;

CARCINOMA, NON-SMALL-CELL LUNG; HUMANS; LUNG NEOPLASMS; NEOPLASM RECURRENCE, LOCAL; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; RISK; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84856595294     PISSN: 09387994     EISSN: 14321084     Source Type: Journal    
DOI: 10.1007/s00330-011-2299-8     Document Type: Review

References (90)

1. A Jemal F Bray MM Center J Ferlay E Ward D Forman 2011 Global cancer statistics CA Cancer J Clin 61 69 90 21296855 10.3322/caac.20107
2. Ferlay J, Shin HR, Bray F (2008) GLOBOCAN Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10. Lyon, France International Agency for Research on Cancer. Available at: http://globocan.iarc.fr. Accessed 16/02/2011
3. Altekruse S, Kosary CL, Krapcho M et al (2010) SEER Cancer Statistics Review, 1975-2007, National Cancer Institute. Bethesda, MD, http://seer.cancer. gov/csr/1975-2007/, based on November 2009 SEER data submission, posted to the SEER web site, 2010. Accessed 3/4/2011
4. R Kanzaki M Higashiyama J Maeda, et al. 2010 Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients Interact Cardiovasc Thorac Surg 10 1009 1014 20197344 10.1510/icvts.2009.227538
5. A Bryant RJ Cerfolio 2007 Differences in epidemiology, histology, and survival between cigarette smokers and never-smokers who develop non-small cell lung cancer Chest 132 185 192 17573517 10.1378/chest.07-0442 (Pubitemid 47068220)
6. CF Mountain 1997 Revisions in the international system for staging lung cancer Chest 111 1710 1717 9187198 10.1378/chest.111.6.1710 1:STN:280: DyaK2szjtVOguw%3D%3D (Pubitemid 27260107)
7. P Van Schil 2003 The restaging issue Lung cancer (Amsterdam, Netherlands) 42 S39 S45 10.1016/S0169-5002(03)00303-9 (Pubitemid 37378185)
8. R Bueno WG Richards SJ Swanson, et al. 2000 Nodal stage after induction therapy for stage IIIA lung cancer determines patient survival Ann Thorac Surg 70 1826 1831 11156079 10.1016/S0003-4975(00)01585-X 1:STN:280: DC%2BD3M%2FpvFersQ%3D%3D (Pubitemid 32015269)
9. KS Virgo FE Johnson KS Naunheim 1999 Follow-up of patients with thoracic malignancies Surg Oncol Clin N Am 8 355 369 10339651 1:STN:280: DyaK1M3nt1yqsg%3D%3D (Pubitemid 29215327)
10. J Rubins M Unger GL Colice 2007 Follow-up and surveillance of the lung cancer patient following curative intent therapy: ACCP evidence-based clinical practice guideline (2nd edition) Chest 132 355S 367S 17873180 10.1378/chest.07-1390
11. R Maeda J Yoshida T Hishida, et al. 2010 Late recurrence of non-small cell lung cancer more than 5 years after complete resection: incidence and clinical implications in patient follow-up Chest 138 145 150 20382716 10.1378/chest.09-3046
12. Y Ichinose H Kato T Koike, et al. 2001 Overall survival and local recurrence of 406 completely resected stage IIIa-N2 non-small cell lung cancer patients: questionnaire survey of the Japan Clinical Oncology Group to plan for clinical trials Lung Cancer 34 29 36 11557110 10.1016/S0169-5002(01)00207-0 1:STN:280:DC%2BD3MrhtVWrsg%3D%3D (Pubitemid 32824120)
13. J Moldvay P Scheid P Wild, et al. 2000 Predictive survival markers in patients with surgically resected non-small cell lung carcinoma Clin Cancer Res 6 1125 1134 10741743 1:STN:280:DC%2BD3c3gtlOrtQ%3D%3D (Pubitemid 30159376)
14. K al-Kattan E Sepsas SW Fountain ER Townsend 1997 Disease recurrence after resection for stage I lung cancer Eur J Cardiothorac Surg 12 380 384 9332915 10.1016/S1010-7940(97)00198-X 1:STN:280:DyaK2svnsVSksQ%3D%3D (Pubitemid 27397975)
15. N Martini MS Bains ME Burt, et al. 1995 Incidence of local recurrence and second primary tumours in resected stage I lung cancer J Thorac Cardiovasc Surg 109 120 129 7815787 10.1016/S0022-5223(95)70427-2 1:STN:280: DyaK2M7hsFertg%3D%3D
16. L Crino W Weder J van Meerbeeck E Felip 2010 Early stage and locally advanced (non-metastatic) non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Ann Oncol 21 v103 v115 20555058 10.1093/annonc/mdq207
17. NR Bogot LE Quint 2004 Imaging of recurrent lung cancer Cancer Imaging 4 61 67 18250010 10.1102/1470-7330.2004.0002
18. RB Ponn 2000 Lightning can strike twice: second primary lung cancers Chest 118 1526 1529 11115430 10.1378/chest.118.6.1526-a 1:STN:280: DC%2BD3M%2FoslKnsA%3D%3D (Pubitemid 32001772)
19. BE Johnson 1998 Second lung cancers in patients after treatment for an initial lung cancer J Natl Cancer Inst 90 1335 1345 9747865 10.1093/jnci/90.18. 1335 1:STN:280:DyaK1cvhvVKgtQ%3D%3D
20. N Martini MR Melamed 1975 Multiple primary lung cancers J Thorac Cardiovasc Surg 70 606 612 170482 1:STN:280:DyaE28%2FivVOksA%3D%3D
21. JB Seo JG Im JM Goo MJ Chung MY Kim 2001 Atypical pulmonary metastases: spectrum of radiologic findings Radiographics 21 403 417 11259704 1:STN:280:DC%2BD3M7mt1agsg%3D%3D (Pubitemid 33707767)
22. T Yano N Hara Y Ichinose, et al. 1994 Local recurrence after complete resection for non-small-cell carcinoma of the lung. Significance of local control by radiation treatment J Thorac Cardiovasc Surg 107 8 12 8283923 1:STN:280:DyaK2c7htFKitA%3D%3D (Pubitemid 24050492)
23. P Hermanek C Wittekind 1994 The pathologist and the residual (R) tumour classification Pathol Res Pract 190 115 123 8058567 10.1016/S0344-0338(11)80700- 4 1:STN:280:DyaK2czjs1Cktw%3D%3D
24. LF de Geus-Oei HF van der Heijden FH Corstens WJ Oyen 2007 Predictive and prognostic value of FDG-PET in nonsmall-cell lung cancer: a systematic review Cancer 110 1654 1664 17879371 10.1002/cncr.22979 (Pubitemid 47557290)
25. KM Jang KS Lee YM Shim, et al. 2003 The rates and CT patterns of locoregional recurrence after resection surgery of lung cancer: correlation with histopathology and tumour staging J Thorac Imaging 18 225 230 14561907 10.1097/00005382-200310000-00003 (Pubitemid 37310725)
26. M Gaeta A Blandino S Pergolizzi, et al. 2003 Patterns of recurrence of bronchioloalveolar cell carcinoma after surgical resection: a radiological, histological, and immunohistochemical study Lung Cancer 42 319 326 14644520 10.1016/S0169-5002(03)00362-3 (Pubitemid 37468545)
27. LE Heyneman EF Patz 2002 PET imaging in patients with bronchioloalveolar cell carcinoma Lung Cancer 38 261 266 12445747 10.1016/S0169-5002(02)00221-0 (Pubitemid 35341800)
28. HS Glazer DJ Aronberg SS Sagel B Emami 1984 Utility of CT in detecting postpneumonectomy carcinoma recurrence AJR Am J Roentgenol 142 487 494 6607631 1:STN:280:DyaL2c7isVOqsA%3D%3D (Pubitemid 14199095)
29. J Gorich SA Beyer-Enke M Flentje I Zuna I Vogt-Moykopf G Van Kaick 1990 Evaluation of recurrent bronchogenic carcinoma by computed tomography Clin Imaging 14 131 137 2372732 10.1016/0899-7071(90)90009-Z 1:STN:280: DyaK3czit1answ%3D%3D (Pubitemid 20297879)
30. D Hellwig A Groschel TP Graeter, et al. 2006 Diagnostic performance and prognostic impact of FDG-PET in suspected recurrence of surgically treated non-small cell lung cancer Eur J Nucl Med Mol Imaging 33 13 21 16151765 10.1007/s00259-005-1919-4 (Pubitemid 41785304)
31. EJ Chae JB Seo SY Kim, et al. 2006 Radiographic and CT findings of thoracic complications after pneumonectomy Radiographics 26 1449 1468 16973775 10.1148/rg.265055156 (Pubitemid 44518774)
32. PH Hollaus PN Wurnig NS Pridun 2003 The natural history of recurrence after bronchoplastic procedures for non-small cell lung cancer Ann Thorac Surg 76 363 369 12902065 10.1016/S0003-4975(03)00337-0 (Pubitemid 36966097)
33. A Cho J Hur WJ Kang, et al. 2010 Usefulness of FDG PET/CT in determining benign from malignant endobronchial obstruction Eur Radiol 21 1077 1087 21113598 10.1007/s00330-010-2006-1
34. SY Kim JB Seo EJ Chae, et al. 2005 Filling defect in a pulmonary arterial stump on CT after pneumonectomy: radiologic and clinical significance AJR Am J Roentgenol 185 985 988 16177420 10.2214/AJR.04.1515
35. X Qiao O Tullgren I Lax F Sirzen R Lewensohn 2003 The role of radiotherapy in treatment of stage I non-small cell lung cancer Lung Cancer 41 1 11 12826306 10.1016/S0169-5002(03)00152-1 (Pubitemid 36765477)
36. GM Videtic KL Stephans 2010 The role of stereotactic body radiotherapy in the management of non-small cell lung cancer: an emerging standard for the medically inoperable patient? Curr Oncol Rep 12 235 241 20446066 10.1007/s11912-010-0108-1
37. M Trovo A Linda I El Naqa C Javidan-Nejad J Bradley 2010 Early and late lung radiographic injury following stereotactic body radiation therapy (SBRT) Lung Cancer 69 77 85 19910075 10.1016/j.lungcan.2009.09.006
38. A Takeda E Kunieda T Takeda, et al. 2008 Possible misinterpretation of demarcated solid patterns of radiation fibrosis on CT scans as tumour recurrence in patients receiving hypofractionated stereotactic radiotherapy for lung cancer Int J Radiat Oncol Biol Phys 70 1057 1065 17905527 10.1016/j.ijrobp.2007. 07.2383 (Pubitemid 351296119)
39. J Eradat F Abtin A Gutierrez R Suh 2011 Evaluation of treatment response after nonoperative therapy for early-stage non-small cell lung carcinoma Cancer J 17 38 48 21263266 10.1097/PPO.0b013e31820a0948
40. Y Matsuo Y Nagata T Mizowaki, et al. 2007 Evaluation of mass-like consolidation after stereotactic body radiation therapy for lung tumours Int J Clin Oncol / Jp Soc Clin Oncol 12 356 362 10.1007/s10147-007-0691-9 (Pubitemid 47573413)
41. HI Libshitz DG Sheppard 1999 Filling in of radiation therapy-induced bronchiectatic change: a reliable sign of locally recurrent lung cancer Radiology 210 25 27 9885581 1:STN:280:DyaK1M7gt12ltQ%3D%3D (Pubitemid 29004278)
42. M Hadziahmetovic BW Loo RD Timmerman, et al. 2010 Stereotactic body radiation therapy (stereotactic ablative radiotherapy) for stage I non-small cell lung cancer-updates of radiobiology, techniques, and clinical outcomes Discov Med 9 411 417 20515609
43. DJ Hoopes M Tann JW Fletcher, et al. 2007 FDG-PET and stereotactic body radiotherapy (SBRT) for stage I non-small-cell lung cancer Lung Cancer 56 229 234 17353064 10.1016/j.lungcan.2006.12.009 (Pubitemid 46590486)
44. Dupuy DE, Mayo-Smith WW, Abbott GF, DiPetrillo T (2002) Clinical applications of radio-frequency tumour ablation in the thorax. Radiographics, 22 Spec No:S259-269 (Pubitemid 41569711)
45. MD Beland EJ Wasser WW Mayo-Smith DE Dupuy 2010 Primary non-small cell lung cancer: review of frequency, location, and time of recurrence after radiofrequency ablation Radiology 254 301 307 20032160
46. JD Bojarski DE Dupuy WW Mayo-Smith 2005 CT imaging findings of pulmonary neoplasms after treatment with radiofrequency ablation: results in 32 tumours AJR Am J Roentgenol 185 466 471 16037522
47. EM Anderson WR Lees AR Gillams 2009 Early indicators of treatment success after percutaneous radiofrequency of pulmonary tumours Cardiovasc Intervent Radiol 32 478 483 19127381 10.1007/s00270-008-9482-6
48. RD Suh AB Wallace RE Sheehan SB Heinze JG Goldin 2003 Unresectable pulmonary malignancies: CT-guided percutaneous radiofrequency ablation-preliminary results Radiology 229 821 829 14657317 10.1148/radiol. 2293021756 (Pubitemid 37467589)
49. A Singnurkar SB Solomon M Go SM Larson H Scho 2010 18F-FDG PET/CT for the prediction and detection of local recurrence after radiofrequency ablation of malignant lung lesions J Nucl Med 51 1833 1840 21078787 10.2967/jnumed.110. 076778
50. RJ Downey 1999 Follow-up of patients with completely resected lung cancer Chest 115 1487 1488 10378535 10.1378/chest.115.6.1487 1:STN:280: DyaK1MzgsVyrsg%3D%3D (Pubitemid 29275631)
51. J Vansteenkiste C Dooms P De Leyn 2009 The multidisciplinarity of stage III non-small cell lung cancer Eur J Cancer 45 92 105 19775608 10.1016/S0959-8049(09)70021-8
52. P De Leyn D Lardinois PE Van Schil, et al. 2007 ESTS guidelines for preoperative lymph node staging for non-small cell lung cancer Eur J Cardiothorac Surg 32 1 8 17448671 10.1016/j.ejcts.2007.01.075 (Pubitemid 46874948)
53. EM Toloza L Harpole DC McCrory 2003 Noninvasive staging of non-small cell lung cancer: a review of the current evidence Chest 123 137S 146S 12527573 10.1378/chest.123.1-suppl.137S (Pubitemid 36135711)
54. A Fritscher-Ravens KH Bohuslavizki L Brandt, et al. 2003 Mediastinal lymph node involvement in potentially resectable lung cancer: comparison of CT, positron emission tomography, and endoscopic ultrasonography with and without fine-needle aspiration Chest 123 442 451 12576364 10.1378/chest.123.2.442 (Pubitemid 36269428)
55. W Yang Z Fu J Yu, et al. 2008 Value of PET/CT versus enhanced CT for locoregional lymph nodes in non-small cell lung cancer Lung Cancer 61 35 43 18177978 10.1016/j.lungcan.2007.11.007
56. P De Leyn J Vansteenkiste P Cuypers, et al. 1997 Role of cervical mediastinoscopy in staging of non-small cell lung cancer without enlarged mediastinal lymph nodes on CT scan Eur J Cardiothorac Surg 12 706 712 9458140 10.1016/S1010-7940(97)00253-4 (Pubitemid 28035533)
57. M Mateu-Navarro R Rami-Porta R Bastus-Piulats L Cirera-Nogueras G Gonzalez-Pont 2000 Remediastinoscopy after induction chemotherapy in non-small cell lung cancer Ann Thorac Surg 70 391 395 10969650 10.1016/S0003-4975(00) 01437-5 1:STN:280:DC%2BD3cvmtFyitQ%3D%3D (Pubitemid 30650961)
58. KS Lee YM Shim J Han, et al. 2000 Primary tumours and mediastinal lymph nodes after neoadjuvant concurrent chemoradiotherapy of lung cancer: serial CT findings with pathologic correlation J Comput Assist Tomogr 24 35 40 10667655 10.1097/00004728-200001000-00007 1:CAS:528:DC%2BD3cXmtlemtb4%3D
59. P De Leyn S Stroobants W De Wever, et al. 2006 Prospective comparative study of integrated positron emission tomography-computed tomography scan compared with remediastinoscopy in the assessment of residual mediastinal lymph node disease after induction chemotherapy for mediastinoscopy-proven stage IIIA-N2 Non-small-cell lung cancer: a Leuven Lung Cancer Group Study J Clin Oncol 24 3333 3339 16849747 10.1200/JCO.2006.05.6341 (Pubitemid 46638886)
60. C Poettgen D Theegarten W Eberhardt, et al. 2007 Correlation of PET/CT findings and histopathology after neoadjuvant therapy in non-small cell lung cancer Oncology 73 316 323 18497503 10.1159/000134474 1:CAS:528: DC%2BD1cXnsVClsLg%3D (Pubitemid 351862022)
61. R Maeda J Yoshida G Ishii, et al. 2010 Long-term survival and risk factors for recurrence instage I non-small cell lung cancer patients with tumours up to 3 cm in maximum dimension Chest 138 357 362 20435660 10.1378/chest.09-3046
62. P Goldstraw J Crowley K Chansky, et al. 2007 The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours J Thorac Oncol 2 706 714 17762336 10.1097/JTO.0b013e31812f3c1a (Pubitemid 47357522)
63. J Yoshida K Nagai H Asamura, et al. 2009 Visceral pleura invasion impact on non-small cell lung cancer patient survival: its implications for the forthcoming TNM staging based on a large-scale nation-wide database J Thorac Oncol 4 959 963 19458555 10.1097/JTO.0b013e3181a85d5e
64. JH Hwang KS Song SI Park TH Lim KH Kwon DE Goo 2005 Subtle pleural metastasis without large effusion in lung cancer patients: preoperative detection on CT Korean J Radiol 6 94 101 15968148 10.3348/kjr.2005.6.2.94
65. T Nakagawa N Okumura K Ohata H Igai T Matsuoka K Kameyama 2008 Postrecurrence survival in patients with stage I non-small cell lung cancer Eur J Cardiothorac Surg 34 499 504 18579404 10.1016/j.ejcts.2008.05.016
66. T Yano H Yokoyama T Inoue, et al. 1994 The first site of recurrence after complete resection in non-small-cell carcinoma of the lung. Comparison between pN0 disease and pN2 disease J Thorac Cardiovasc Surg 108 680 683 7934102 1:STN:280:DyaK2M%2FhvFOntg%3D%3D (Pubitemid 24330244)
67. W De Wever S Ceyssens L Mortelmans, et al. 2007 Additional value of PET-CT in the staging of lung cancer: comparison with CT alone, PET alone and visual correlation of PET and CT Eur Radiol 17 23 32 16683115 10.1007/s00330-006-0284-4 (Pubitemid 46063025)
68. W De Wever Y Vankan S Stroobants J Verschakelen 2007 Detection of extrapulmonary lesions with integrated PET/CT in the staging of lung cancer Eur Respir J 29 995 1002 17331966 10.1183/09031936.00119106 (Pubitemid 46711906)
69. JF Vansteenkiste 2002 Imaging in lung cancer: positron emission tomography scan Eur Respir J 35 49s 60s 10.1183/09031936.02.00252402 1:STN:280:DC%2BD38zitFyltg%3D%3D
70. D Takenaka Y Ohno H Koyama, et al. 2010 Integrated FDG-PET/CT vs. standard radiological examinations: comparison of capability for assessment of postoperative recurrence in non-small cell lung cancer patients Eur J Radiol 74 458 464 19398291 10.1016/j.ejrad.2009.03.007
71. Onishi Y, Ohno Y, Koyama H et al (2010) Non-small cell carcinoma: Comparison of postoperative intra- and extrathoracic recurrence assessment capability of qualitatively and/or quantitatively assessed FDG-PET/CT and standard radiological examinations. Eur J Radiol doi:10.1016/j.ejrad.2010.04.027
72. FC Detterbeck MA Jantz M Wallace J Vansteenkiste GA Silvestri 2007 Invasive mediastinal staging of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition) Chest 132 202S 220S 17873169 10.1378/chest.07-1362
73. MP Revel A Merlin S Peyrard, et al. 2006 Software volumetric evaluation of doubling times for differentiating benign versus malignant pulmonary nodules AJR Am J Roentgenol 187 135 142 16794167 10.2214/AJR.05.1228 (Pubitemid 46100159)
74. T Hishida K Nagai J Yoshida, et al. 2006 Is surgical resection indicated for a solitary non-small cell lung cancer recurrence? J Thorac Cardiovasc Surg 131 838 842 16580442 10.1016/j.jtcvs.2005.11.028
75. SJ Swensen RW Viggiano DE Midthun, et al. 2000 Lung nodule enhancement at CT: multicenter study Radiology 214 73 80 10644104 1:STN:280: DC%2BD3c7gs12hsg%3D%3D (Pubitemid 30019872)
76. F Girvin JP Ko 2008 Pulmonary nodules: detection, assessment, and CAD AJR Am J Roentgenol 191 1057 1069 18806142 10.2214/AJR.07.3472
77. TD Poeppel BJ Krause TA Heusner C Boy A Bockisch G Antoch 2009 PET/CT for the staging and follow-up of patients with malignancies Eur J Radiol 70 382 392 19406595 10.1016/j.ejrad.2009.03.051 1:STN:280:DC%2BD1Mvhs1KgsQ%3D%3D
78. K Yokoi N Kamiya H Matsuguma, et al. 1999 Detection of brain metastasis in potentially operable non-small cell lung cancer: a comparison of CT and MRI Chest 115 714 719 10084481 10.1378/chest.115.3.714 1:STN:280: DyaK1M7otF2ksA%3D%3D (Pubitemid 29129950)
79. EM Marom HP McAdams JJ Erasmus, et al. 1999 Staging non-small cell lung cancer with whole-body PET Radiology 212 803 809 10478250 1:STN:280: DyaK1MvgslKrug%3D%3D (Pubitemid 29410986)
80. HY Lee KS Lee BT Kim, et al. 2009 Diagnostic efficacy of PET/CT plus brain MR imaging for detection of extrathoracic metastases in patients with lung adenocarcinoma J Korean Med Sci 24 1132 1138 19949671 10.3346/jkms.2009.24.6. 1132
81. RF Munden SS Swisher CW Stevens DJ Stewart 2005 Imaging of the patient with non-small cell lung cancer Radiology 237 803 818 16251391 10.1148/radiol.2373040966 (Pubitemid 41636367)
82. WW Mayo-Smith GW Boland RB Noto MJ Lee 2001 State-of-the-art adrenal imaging Radiographics 21 995 1012 11452074 1:STN:280:DC%2BD3MvgtVyhsg%3D%3D
83. MA Blake JM Slattery MK Kalra, et al. 2006 Adrenal lesions: characterization with fused PET/CT image in patients with proved or suspected malignancy-initial experience Radiology 238 970 977 16505394 10.1148/radiol.2383042164 (Pubitemid 43289929)
84. U Metser E Miller H Lerman G Lievshitz S Avital E Even-Sapir 2006 18-F-FDG PET/CT in the evaluation of adrenal masses J Nucl Med 47 32 37 16391184 (Pubitemid 46768509)
85. MJ Brady J Thomas TZ Wong KM Franklin LM Ho EK Paulson 2009 Adrenal nodules at FDG PET / CT in patients known to have or suspected of having lung cancer. A proposal for an efficient diagnostic algorithm Radiology 250 523 530 19188319 10.1148/radiol.2502080219
86. S Takeda S Fukai H Komatsu E Nemoto K Nakamura M Murakami 2005 Impact of large tumour size on survival after resection of pathologically node negative (pN0) non-small cell lung cancer Ann Thorac Surg 79 1142 1146 15797041 10.1016/j.athoracsur.2004.09.062 (Pubitemid 40431830)
87. M Kamiyoshihara O Kawashima S Sakata T Hirai S Ishikawa Y Morishita 1999 Does an incomplete interlobar fissure influence survival or recurrence in resected non-small-cell lung cancer? Lung cancer (Amsterdam, Netherlands) 25 33 38 10.1016/S0169-5002(99)00047-1 1:STN:280:DyaK1MzpsVOmtQ%3D%3D (Pubitemid 29325004)
88. VS Nair PG Barnett L Ananth MK Gould 2010 PET scan 18F-fluorodeoxyglucose uptake and prognosis in patients with resected clinical stage IA non-small cell lung cancer Chest 137 1150 1156 20038738 10.1378/chest.09-2356
89. K Higashi Y Ueda Y Arisaka, et al. 2002 18F-FDG uptake as a biologic prognostic factor for recurrence in patients with surgically resected non-small cell lung cancer J Nucl Med 43 39 45 11801701 (Pubitemid 34101186)
90. L Moretti DS Yu H Chen, et al. 2009 Prognostic factors for resected non-small cell lung cancer with pN2 status: implications for use of postoperative radiotherapy Oncologist 14 1106 1115 19897534 10.1634/ theoncologist.2009-0130